-The Telegraph New Delhi: A public health expert has questioned the Indian government's commitment to effectively tackling tuberculosis, citing slashed funds, late diagnoses and a failure to curb incorrect or inappropriate prescriptions by many private practitioners. India's plans to eliminate TB as a public health problem by 2050 will remain unachievable without sustained financial support, strong political will and stringent regulation, Mahavir Golechha has said. Golechha is a faculty member with the health...
More »SEARCH RESULT
Patients' groups voice patent fears
-The Telegraph New Delhi: Health and Patients' rights groups have called on the government to resist American pressure that they claimed was aimed at weakening safeguards in India's patent laws that allow drug companies to sell inexpensive generic medicine. Health activists representing Patients' rights said they were concerned that bilateral talks on intellectual property rights, to feature during US President Barack Obama's visit to India beginning this weekend, may be rigged against...
More »Obama visit: civil society appeals to Modi not to succumb to US pressure on IP laws -Kundan Pandey
-Down to Earth US actions jeopardise India's pro-poor patent laws that promote generic drugs production, says online global petition More than 75,000 people have requested Prime Minister Narendra Modi not to succumb to US pressure on Intellectual Property Rights (IP). With trade and intellectual property rights featuring prominently in the agenda of US president Barak Obama's India visit, civil society groups have expressed concern that talks on these issues are designed to make...
More »Fillip to cheaper hepatitis C drug -GS Mudur
-The Telegraph New Delhi: India's patent regulating agency today rejected a US company's patent claim on a drug to treat hepatitis C, raising hopes that generic drug makers could now produce cheaper versions of the medicine. The Indian Patents Controller has denied a patent to sofosbuvir from Gilead, a US biopharmaceutical company that had last year pledged to make the oral drug available in India and 90 other developing countries at $900...
More »Good scheme in bad health -Kundan Pandey
-Down to Earth The primary health centre (PHC) at Ajara block in Maharashtra's Kolhapur district would handle just eight childbirth cases a year till 2011. Today, it handles over 125 such cases in a year. The health centre became efficient because of a Central government scheme that empowers communities to monitor public health services. In 2010, the residents participated in a jan sunwai (public hearing) session, in which they told senior...
More »